Joe G. Hollyfield – författare
890 kr
Skickas inom 10-15 vardagar
1 112 kr
Skickas inom 10-15 vardagar
2 216 kr
Skickas inom 10-15 vardagar
2 216 kr
Skickas inom 10-15 vardagar
2 925 kr
Läs direkt efter köp
Retinal Degenerations is the result of the International Symposium on Retinal degeneration which has become perhaps the most important research meeting in the field. THe topics in this volume explore the etiology, cellular mechanisms, epidemiology, genetics, models and potential therapeutic measures for the blinding diseases of retinitis pigmentosa and age-related macular degeneration.
2 216 kr
Skickas inom 10-15 vardagar
2 822 kr
Läs direkt efter köp
Retinal Degenerations is the result of The International Symposium on Retinal Degeneration which has become perhaps the most important research meeting in the field. The topics in this volume explore the etiology, cellular mechanisms, epidemiology, generics, models and potential therapeutic measures for the blinding diseases of retinitis pigmentosa and age-related macular degeneration.
Special focus is highlighted in the areas of Mechanisms of Photoreceptor Degeneration and Cell Death (extremely important because very little is known how or why photoreceptors die in these diseases, despite an abundance of genetic information), Age-Related Macular Degeneration (with several novel approaches to its analysis), Usher Syndrome (the most severe form of retinitis pigmentosa, which includes an early of congenital loss of hearing along with blindness), and Gene Therapy. In addition, the section on Basic Science Related to Retinal Degeneration is particularly strong with several laboratories reporting on new discoveries in the area of outer segment phagocytosis, a key component of photoreceptor-retinal pigment epithelial cell interactions in normal and degenerating retinas.
734 kr
Läs direkt efter köp
3 330 kr
Skickas inom 10-15 vardagar
4 066 kr
Läs direkt efter köp
2 222 kr
Skickas inom 10-15 vardagar
2 222 kr
Skickas inom 10-15 vardagar
1 115 kr
Skickas inom 10-15 vardagar
561 kr
Skickas inom 10-15 vardagar
561 kr
Skickas inom 10-15 vardagar
561 kr
Skickas inom 10-15 vardagar
3 330 kr
Skickas inom 10-15 vardagar
3 251 kr
Läs direkt efter köp
3 330 kr
Skickas inom 10-15 vardagar
4 066 kr
Läs direkt efter köp
This book will contain the proceedings of the XV International Symposium on Retinal Degeneration (RD2012). A majority of those who will speak and present posters at the meeting will contribute to this volume. The blinding diseases of inherited retinal degenerations have no treatments, and age-related macular degeneration has no cures, despite the fact that it is an epidemic among the elderly, with 1 in 3-4 affected by the age of 70. The RD Symposium will focus on the exciting new developments aimed at understanding these diseases and providing therapies for them. Since most major scientists in the field of retinal degenerations attend the biennial RD Symposia, they are known by most as the “best” and “most important” meetings in the field.
The volume will present representative state-of-the-art research in almost all areas of retinal degenerations, ranging from cytopathologic, physiologic, diagnostic and clinical aspects; animal models; mechanisms of cell death; candidate genes, cloning, mapping and other aspects of molecular genetics; and developing potential therapeutic measures such as gene therapy and neuroprotective agents for potential pharmaceutical therapy.
While advances in these areas of retinal degenerations will be described, there will be many new topics that either were in their infancy or did not exist at the time of the last RD Symposium, RD2010. These include the role of inflammation and immunity, as well as other basic mechanisms, in age-related macular degeneration, several new aspects of gene therapy, and revolutionary new imaging and functional testing that will have a huge impact on the diagnosis and following the course of retinal degenerations, as well as to provide new quantitative endpoints for clinical trials.
The retina is an approachable part of the central nervous system (CNS), and there is a major interest in neuroprotective and gene therapy for CNS diseases andneurodegenerations, in general. It should be noted that with successful and exciting initial clinical trials in neuroprotective and gene therapy, including the restoration of sight in blind children, the retinal degeneration therapies are leading the way towards new therapeutic measures for neurodegenerations of the CNS. Many of the successes recently reported in these areas of retinal degeneration sprang from collaborations established at previous RD Symposia, and many of those will be reported at the RD2010 meeting and included in the proposed volume. We anticipate the excitement of those working in the field and those afflicted with retinal degenerations will be reflected in the volume.
2 822 kr
Läs direkt efter köp
1 459 kr
Läs direkt efter köp
734 kr
Läs direkt efter köp
708 kr
Läs direkt efter köp
734 kr
Läs direkt efter köp
561 kr
Skickas inom 10-15 vardagar
2 222 kr
Skickas inom 10-15 vardagar
3 274 kr
Skickas inom 5-8 vardagar
3 330 kr
Skickas inom 10-15 vardagar
3 330 kr
Skickas inom 10-15 vardagar